Hughes Jonathan D, Shin Jason J, Albers Marcio, Musahl Volker, Fu Freddie H
Baylor Scott & White Medical Center-Temple, Temple, Texas, USA.
UPMC Rooney Sports Complex, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Orthop J Sports Med. 2019 Jan 22;7(1):2325967118823175. doi: 10.1177/2325967118823175. eCollection 2019 Jan.
A recent study demonstrated that discrepancies exist between disclosures reported by authors publishing in and disclosures listed in the Physician Payments Sunshine Act-initiated Open Payments database, managed by the Centers for Medicare & Medicaid Services (CMS). However, no study to date has explored the relationship between the biopharmaceutical and device industry (industry) and the membership base of the American Orthopaedic Society for Sports Medicine (AOSSM).
To critically examine the relationship between orthopaedic sports medicine surgeons and industry.
Cross-sectional study.
The publicly available CMS Open Payments database website was accessed to search for sports medicine orthopaedic surgeons in the United States who were members of the AOSSM. Financial data, specifically general, research, and ownership payments for 2015, were recorded for each surgeon. The American Academy of Orthopaedic Surgeons (AAOS) disclosures of each surgeon were then obtained. Descriptive statistics and simple proportions were calculated to summarize the collected data, including years in practice and amount of payment. Median values for general payments were compared to provide a more accurate reflection of payments transferred to a "typical" sports medicine surgeon.
A total of $58,113,561 in general payments, $3,996,051 in research payments, $72,481,814 in money invested, and $144,552,383 in interest earned from money invested were identified as being paid to 2274 surgeons (all amounts in US$). The distribution of total general payments received was skewed: 10% of surgeons received 95.4% ($55,463,183) of the total general payments. A total of 1433 surgeons had completed, up-to-date AAOS disclosures. Although 44% (635 surgeons) self-reported no financial conflict to the AAOS, the Open Payments database indicated some level of industry support to these surgeons. Unreported general payments totaled $1,393,212, or a median of $561 per surgeon (interquartile range, $10-$200,048).
Although orthopaedic sports medicine surgeons received substantial payments from industry, most of the total general payments were given to a small proportion of people. The regional distribution of these payments did not differ significantly. Summary reports of data are largely skewed by outliers and should be interpreted with caution. However, a large percentage of these surgeons failed to reveal industry support of any kind in their AAOS disclosures, including meals and educational funding, demonstrating the importance of transparency and accuracy when completing financial disclosures.
最近一项研究表明，在[期刊名称未给出]上发表文章的作者所报告的利益披露与由医疗保险和医疗补助服务中心（CMS）管理的、依据《医师薪酬阳光法案》建立的公开支付数据库中列出的披露之间存在差异。然而，迄今为止尚无研究探讨生物制药和器械行业与美国运动医学骨科协会（AOSSM）会员群体之间的关系。
批判性地研究骨科运动医学外科医生与行业之间的关系。
横断面研究。
访问公开的CMS公开支付数据库网站，以搜索美国AOSSM会员中的骨科运动医学外科医生。记录了每位外科医生2015年的财务数据，具体包括一般支付、研究支付和所有权支付。然后获取了每位外科医生在美国骨科医师学会（AAOS）的披露信息。计算描述性统计数据和简单比例以总结所收集的数据，包括从业年限和支付金额。比较一般支付的中位数，以更准确地反映转给“典型”运动医学外科医生的支付情况。
共识别出向2274名外科医生支付了总计58,113,561美元的一般支付、3,996,051美元的研究支付、72,481,814美元的投资金额以及144,552,383美元的投资收益（所有金额均以美元计）。所收到的一般支付总额的分布存在偏差：10%的外科医生获得了一般支付总额的95.4%（55,463,183美元）。共有1433名外科医生完成了最新的AAOS披露。尽管44%（635名外科医生）向AAOS自我报告无财务冲突，但公开支付数据库显示这些外科医生获得了一定程度的行业支持。未报告的一般支付总计1,393,212美元，每位外科医生的中位数为561美元（四分位距为10 - 200,048美元）。
尽管骨科运动医学外科医生从行业获得了大量支付，但大部分一般支付总额都给予了一小部分人。这些支付的地区分布没有显著差异。数据总结报告在很大程度上受到异常值的影响，应谨慎解读。然而，很大比例的这些外科医生在其AAOS披露中未透露任何形式的行业支持（包括餐费和教育资金），这表明在完成财务披露时透明度和准确性的重要性。
